Date |
Time |
Source |
Heading |
4/25/2024 | 8:52 | IHNW | FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA |
4/19/2024 | 07:13 | GLOBE | Ocugen Announces Dosing Completion of Subjects with.. |
4/12/2024 | 07:30 | GLOBE | Ocugen to Participate in Fireside Chat at the Emerging.. |
4/10/2024 | 07:02 | GLOBE | Ocugen, Inc. Announces Positive Scientific Advice from the.. |
4/08/2024 | 06:30 | GLOBE | Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment.. |
4/05/2024 | 07:02 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
4/02/2024 | 08:00 | GLOBE | Ocugen Provides Business Update with Certain Financials for.. |
4/01/2024 | 18:08 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
4/01/2024 | 17:43 | GLOBE | Ocugen to Host Conference Call on Tuesday, April 2 at 8:30.. |
3/18/2024 | 06:30 | GLOBE | Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical.. |
3/13/2024 | 08:00 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
3/06/2024 | 07:30 | GLOBE | Ocugen to Present at Investing in Cures Summit |
2/28/2024 | 08:00 | GLOBE | Ocugen Clinical Showcase Webcast Now Available |
2/26/2024 | 08:30 | GLOBE | Ocugen Chairman and CEO to present at Abu Dhabi Family.. |
2/22/2024 | 16:05 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
2/21/2024 | 16:05 | GLOBE | Ocugen to Present at 2024 BIO CEO & Investor Conference |
2/21/2024 | 11:22 | EDGAR2 | Form 8-K - Current report |
2/14/2024 | 07:30 | GLOBE | Ocugen to Host Clinical Showcase in New York City.. |
1/31/2024 | 08:00 | GLOBE | Ocugen to Present at Pharma Market Research Conference |
1/16/2024 | 07:30 | GLOBE | Ocugen, Inc. Announces Bob Smith Joins Business Advisory.. |
1/08/2024 | 06:05 | EDGAR2 | Form 8-K - Current report |
1/05/2024 | 16:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
1/05/2024 | 16:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
1/04/2024 | 17:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
1/04/2024 | 17:04 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/22/2023 | 15:09 | EDGAR2 | Form 8-K - Current report |
12/21/2023 | 06:30 | GLOBE | Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier.. |
12/19/2023 | 07:30 | GLOBE | Ocugen Announces OCU400 Receives Regenerative Medicine.. |
12/13/2023 | 07:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
11/29/2023 | 07:30 | GLOBE | Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’.. |
11/10/2023 | 07:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
11/09/2023 | 08:02 | EDGAR2 | Form 8-K - Current report |
11/09/2023 | 07:02 | EDGAR2 | Form 8-K - Current report |
11/09/2023 | 06:30 | GLOBE | Ocugen Provides Business Update with Third Quarter 2023.. |
11/09/2023 | 06:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/07/2023 | 07:45 | GLOBE | Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic.. |
11/02/2023 | 07:30 | GLOBE | Ocugen to Host Conference Call on Thursday, November 9 at.. |
10/10/2023 | 09:05 | EDGAR2 | Form 8-K - Current report |
10/10/2023 | 06:30 | GLOBE | Ocugen Mucosal Vaccine Candidate OCU500 Selected by.. |
10/04/2023 | 07:00 | GLOBE | Ocugen to Present at the 2023 Cell & Gene Meeting on the.. |
9/29/2023 | 07:30 | GLOBE | Ocugen CSO to Participate in 4th Annual Gene Therapy for.. |
9/27/2023 | 19:30 | GLOBE | Ocugen to Participate in Fireside Chat at Chardan’s 7th.. |
9/21/2023 | 07:30 | GLOBE | Ocugen, Inc. Announces Connie Collingsworth Joins Business.. |
9/20/2023 | 08:00 | GLOBE | Ocugen to Participate in Panel at Cantor Fitzgerald Global.. |
9/19/2023 | 16:54 | EDGAR2 | Form 8-K - Current report |
9/19/2023 | 16:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
9/13/2023 | 08:28 | EDGAR2 | Form 8-K - Current report |
9/13/2023 | 08:15 | GLOBE | Ocugen Announces Positive Clinical Study Update from the.. |
9/12/2023 | 19:30 | GLOBE | Ocugen to Host Virtual Investor & Analyst Event on September.. |
8/22/2023 | 09:12 | EDGAR2 | Form 8-K - Current report |
8/21/2023 | 16:48 | EDGAR2 | Form 8-K - Current report |